Cargando…

(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside

Hepatocellular carcinoma (HCC) is the 5th most common tumour worldwide and has a dark prognosis. For nonoperable cases, metabolic radiotherapy with Lipiodol labelled with β-emitters is a promising therapeutic option. The Comprehensive Cancer Centre Eugène Marquis and the National Graduate School of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lepareur, Nicolas, Ardisson, Valérie, Noiret, Nicolas, Garin, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299367/ https://www.ncbi.nlm.nih.gov/pubmed/22518301 http://dx.doi.org/10.1155/2012/278306

Ejemplares similares

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019)

Lipid Nanocapsules Loaded with Rhenium-188 Reduce Tumor Progression in a Rat Hepatocellular Carcinoma Model
por: Vanpouille-Box, Claire, et al.
Publicado: (2011)

(188) Re-N-DEDC Lipiodol for Treatment of Hepatocellular Carcinoma (HCC)—A Clinical and Prospective Study to Assess In-Vivo Distribution in Patients and Clinical Feasibility of Therapy
por: Kumar, Naresh, et al.
Publicado: (2023)

Intensive Sleep Re-Training: From Bench to Bedside
por: Lack, Leon, et al.
Publicado: (2017)

Biodistribution, pharmacokinetics, and organ-level dosimetry for (188)Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans
por: Esquinas, Pedro L., et al.
Publicado: (2018)

(68)Ga and (188)Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies
por: Verger, Elise, et al.
Publicado: (2016)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
por: Sun, HongLiang, et al.
Publicado: (2017)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Glucocorticoid Signaling Pathway: From Bench to Bedside
por: Nicolaides, Nicolas C., et al.
Publicado: (2023)

SSS transport
por: Sylvie Prodon
Publicado: (2006)

Locoregional Confinement and Major Clinical Benefit of (188)Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma
por: Séhédic, Delphine, et al.
Publicado: (2017)

Study of Binding Kinetics and Specificity of (99m)Tc-SSS-Complex and (99m)Tc-HMPAO to Blood Cells
por: Auletta, S., et al.
Publicado: (2018)

Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response
por: Dioguardi Burgio, Marco, et al.
Publicado: (2019)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Preparation for and installation of SSS'S
por: Rohmig, P
Publicado: (2003)

Recent Developments in Pharmacotherapy of Depression: Bench to Bedside
por: Shad, Mujeeb U.
Publicado: (2023)

Rhenium-188 Production in Hospitals, by W-188/Re-188 Generator, for Easy Use in Radionuclide Therapy
por: Argyrou, Maria, et al.
Publicado: (2013)

Bench-to-bedside review: β-Adrenergic modulation in sepsis
por: de Montmollin, Etienne, et al.
Publicado: (2009)

Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides
por: Lepareur, Nicolas, et al.
Publicado: (2015)

From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
por: Gardner, Christopher R., et al.
Publicado: (2023)

Efficacy and Safety of Combined Ethanol-Lipiodol Mixture and Drug-Eluting Bead TACE for Large HCC
por: Chuang, Yi-Hsuan, et al.
Publicado: (2023)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
por: Lechner, Matt, et al.
Publicado: (2020)

Bench-to-bedside development of multifunctional flexible embolic agents
por: Wang, Dawei, et al.
Publicado: (2023)

Rett syndrome from bench to bedside: recent advances
por: Ehinger, Yann, et al.
Publicado: (2018)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Development of new levodopa treatment strategies in Parkinson’s disease—from bedside to bench to bedside
por: Aquilonius, Sten-Magnus, et al.
Publicado: (2017)

Bench-to-bedside review: An approach to hemodynamic monitoring - Guyton at the bedside
por: Magder, Sheldon
Publicado: (2012)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

Lipiodol and the Lung
Publicado: (1935)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3r1o92g6q7lurcav80a1gk671u